Universal Biosensors Inc
Company Profile
- Business description- Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. It has one reportable segment: specialist biosensors company. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets. 
- Contact- 1 Corporate Avenue 
 RowvilleVIC3178
 AUS- T: +61 392139000 
- Sector- Healthcare - Stock type- Defensive 
- Industry- Medical Devices - Fiscal Year End- 31 December 2025 - Employees- 76 
Stocks News & Analysis
stocks
Microsoft earnings: Strong, including Azure, but overall guidance is in line
stocks
After earnings, is Tesla stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Markets
| Index | Last price | Change | % Change | 
|---|---|---|---|
| All Ordinaries | 9,178.00 | 28.70 | -0.31% | 
| CAC 40 | 8,113.47 | 43.82 | -0.54% | 
| DAX 40 | 23,944.08 | 174.81 | -0.72% | 
| Dow JONES (US) | 47,595.62 | 73.50 | 0.15% | 
| FTSE 100 | 9,717.80 | 42.26 | -0.43% | 
| HKSE | 25,906.65 | 376.04 | -1.43% | 
| NASDAQ | 23,793.46 | 212.31 | 0.90% | 
| Nikkei 225 | 52,411.34 | 1,085.73 | 2.12% | 
| NZX 50 Index | 13,548.32 | 89.03 | 0.66% | 
| S&P 500 | 6,854.53 | 32.19 | 0.47% | 
| S&P/ASX 200 | 8,881.90 | 31.30 | -0.35% | 
| SSE Composite Index | 3,954.79 | 32.11 | -0.81% |